Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.
D000284:Administration, Oral; D000328:Adult; D000917:Antibody Formation; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis; D007167:Immunotherapy; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012882:Skin Tests; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use*
D001500:BCG Vaccine; D003561:Cytarabine; D014750:Vincristine; D011241:Prednisone